Literature DB >> 19859817

Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis.

Linhui Wang1, Liang Wang, Bo Yang, Qing Yang, Shouyi Qiao, Yingming Wang, Yinghao Sun.   

Abstract

The chemokine receptor CXCR4 is involved in the metastasis of many cancers. Recent evidence suggests that CXCR4 may be also involved in the metastasis of renal cell carcinoma. We analyzed the expression of CXCR4 in primary carcinomas, metastatic tissues and normal tissues using immunohistochemistry. We further investigated the migration of renal carcinoma cells in response to stimulation by CXCL12 in vitro. We also studied the subcellular localization of CXCR4 in renal cell carcinoma cells in response to CXCL12 by confocal microscopy. We observed the highest percentage of CXCR4 expression in renal cell carcinoma metastases compared with that in renal cell carcinomas and normal renal tissues. We further found that CXCR4 was localized predominantly in the membrane in primary renal cell carcinomas and predominantly in the cytoplasm in renal cell carcinoma metastases. Moreover, we found that CXCR4 was translocated from the cytoplasmic membrane to the cytoplasm upon stimulation by its ligand CXCL12. Renal cell carcinoma metastasis was associated with higher expression of CXCR4 and interaction of CXCR4 and its ligand CXCL12 resulted in the internalization of CXCR4 from the cytoplasmic membrane. These findings implicate the CXCR4-CXCL12 axis in the metastasis of renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19859817     DOI: 10.1007/s10585-009-9294-3

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  24 in total

Review 1.  Lymphocyte trafficking and regional immunity.

Authors:  E C Butcher; M Williams; K Youngman; L Rott; M Briskin
Journal:  Adv Immunol       Date:  1999       Impact factor: 3.543

Review 2.  Chemokines in tissue-specific and microenvironment-specific lymphocyte homing.

Authors:  J J Campbell; E C Butcher
Journal:  Curr Opin Immunol       Date:  2000-06       Impact factor: 7.486

3.  Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma.

Authors:  S A Rempel; S Dudas; S Ge; J A Gutiérrez
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

Review 4.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

5.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

Review 6.  Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

7.  Molecular cloning and structure of a pre-B-cell growth-stimulating factor.

Authors:  T Nagasawa; H Kikutani; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

8.  Transcriptional targeting in renal cancer cell lines via the human CXCR4 promoter.

Authors:  Yosef S Haviv; Winan J van Houdt; Baogen Lu; David T Curiel; Zeng B Zhu
Journal:  Mol Cancer Ther       Date:  2004-06       Impact factor: 6.261

9.  Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.

Authors:  J-P Spano; F Andre; L Morat; L Sabatier; B Besse; C Combadiere; P Deterre; A Martin; J Azorin; D Valeyre; D Khayat; T Le Chevalier; J-C Soria
Journal:  Ann Oncol       Date:  2004-04       Impact factor: 32.976

10.  CXCR4/CXCL12 expression and signalling in kidney cancer.

Authors:  A J Schrader; O Lechner; M Templin; K E J Dittmar; S Machtens; M Mengel; M Probst-Kepper; A Franzke; T Wollensak; P Gatzlaff; J Atzpodien; J Buer; J Lauber
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640

View more
  18 in total

1.  Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.

Authors:  Arezoo Rasti; Maryam Abolhasani; Leili Saeednejad Zanjani; Mojgan Asgari; Mitra Mehrazma; Zahra Madjd
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-16       Impact factor: 4.553

2.  Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.

Authors:  Jeffrey C Gahan; Miguel Gosalbez; Travis Yates; Ezekiel E Young; Diogo O Escudero; Andrew Chi; Michael Garcia-Roig; Ramgopal Satyanarayana; Mark S Soloway; Vincent G Bird; Vinata B Lokeshwar
Journal:  J Urol       Date:  2012-01-15       Impact factor: 7.450

3.  A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC).

Authors:  John D Hainsworth; James A Reeves; Joseph R Mace; Edward J Crane; Oday Hamid; John R Stille; Amy Flynt; Stephanie Roberson; John Polzer; Edward R Arrowsmith
Journal:  Target Oncol       Date:  2016-10       Impact factor: 4.493

4.  Significance of CXCR4, phosphorylated STAT3 and VEGF-A expression in resected non-small cell lung cancer.

Authors:  Meng Wang; Gong-Yan Chen; Hong-Tao Song; Xuan Hong; Zhao-Yang Yang; Guang-Jie Sui
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

5.  Expression of chemokine receptor CXCR4 is closely correlated with clinical outcome in human nasopharyngeal carcinoma.

Authors:  Hengmin Tao; Yumei Wei; Congan Wang; Kun Yang; Wei Huang; Haitao Liu; Baosheng Li
Journal:  Tumour Biol       Date:  2015-11-26

6.  Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer.

Authors:  Chang-Shuo Huang; Shye-Jye Tang; Ling-Yen Chung; Cheng-Ping Yu; Jar-Yi Ho; Tai-Lung Cha; Chii-Cheng Hsieh; Hsiao-Hsien Wang; Guang-Huan Sun; Kuang-Hui Sun
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

Review 7.  The intricate role of CXCR4 in cancer.

Authors:  Samit Chatterjee; Babak Behnam Azad; Sridhar Nimmagadda
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

Review 8.  Types of nuclear localization signals and mechanisms of protein import into the nucleus.

Authors:  Juane Lu; Tao Wu; Biao Zhang; Suke Liu; Wenjun Song; Jianjun Qiao; Haihua Ruan
Journal:  Cell Commun Signal       Date:  2021-05-22       Impact factor: 5.712

9.  The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer.

Authors:  A Popple; L G Durrant; I Spendlove; P Rolland; I V Scott; S Deen; J M Ramage
Journal:  Br J Cancer       Date:  2012-03-13       Impact factor: 7.640

Review 10.  The Role of CXCL12 in Kidney Diseases: A Friend or Foe?

Authors:  Anni Song; Anni Jiang; Wei Xiong; Chun Zhang
Journal:  Kidney Dis (Basel)       Date:  2021-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.